Financials
- Financial year
- 2025
- Total assets
- €437,825
- Profit
- €47,651
- Solvency
- 31.3%
Total assets▼ 4.1%
Net result
20192025
Summary
Camba-Pharma has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €137,100 and a net result of €47,651. Equity is growing by about 40% per year across the filed financial years. Its solvency ranks better than 48% of 22,576 sector peers (NACE 47, financial year 2025). The company has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€437,825total assets 2025
- Equity
- €137,100
- Profit
- €47,651
Turnover not published (micro format)
Financial health
Holding: outside the score modelBankruptcy probability: sector outside the model
SignalsneutralLatest accounts filed on timeShow the evidence
Checked score
Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Bankruptcy probability, 12 months
This is a financial institution (bank, insurer or financial holding). A bank balance sheet works differently from that of an ordinary trading or manufacturing company. We therefore show no bankruptcy probability rather than a misleading figure.
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-04-2026, 114 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
114 days early
2024
13 days early
2023
12 days early
2022
29 days early
2021
26 days early
2020
46 days early
2019
31 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 30 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 5 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · micro…
- Highest result from 2019 to 2025net €47,651 ▲28.9%
- Annual accounts filedfinancial year 2024 · micro…
Key points
By topic
Board & ownership
- Board
- 1 member
- Camille BAETSLÉDirector
Network & group
- Holdings
- 1
1 holding
Timeline
- Events
- 10
- Since
- 2020
- Next accounts
- by 31-07-2027
- 31-12-2024Equity above €100,000
- 19-07-2024Annual accounts filed
- 29-12-2023Resignation: Camille BAETSLÉ (director)
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 07-01-2019
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 33
- Who signs
- Each director alone
- Annual meeting
- In June at 20:00
- Purpose
- “Het verlenen van alle mogelijk advies en managementondersteuning voor de algemene…” (deed in Dutch)
Key facts about Camba-Pharma
- What is the company number of Camba-Pharma?
- 0717.740.414. In Belgium the VAT number is the company number with BE in front: BE 0717.740.414.
- Where is Camba-Pharma based?
- The registered office is at Droogveldeweg 7, 9031 Gent.Company details
- What does Camba-Pharma do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Camba-Pharma?
- Private limited company (BV).
- When was Camba-Pharma founded?
- On 07-01-2019.
- Is Camba-Pharma still active?
- Yes, Camba-Pharma is an active enterprise in the KBO register.
- What is the turnover of Camba-Pharma?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
- Is Camba-Pharma profitable?
- In financial year 2025, Camba-Pharma made a profit of €47,651.
- Where can I find the annual accounts of Camba-Pharma?
- Camba-Pharma filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Camba-Pharma due?
- By 31-07-2027, for financial year 2026.Timeline
Companies related to Camba-Pharma
Subsidiaries and holdings
- BIOCLIN50%
Comparable companies
- APOTHEEK STALPAERTBoutersem
- Pharmacies by Medi-Market GroupEvere
- Apotheek De GeyterZottegem
- PHARMACIE DE LONZEEGembloux
- TANNHAUSER PHARAESCOSKoekelberg
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What changed in the latest annual accounts?What changed What were this company's board, registered office and name on a given date?Company as of a date
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.